The global CRISPR and Cas gene market reached approximately $3.3 billion in 2023, growing at a CAGR of 20.38% since 2018. It is projected to expand to $8.8 billion by 2028 and $24.6 billion by 2033, driven by advancements in cancer therapeutics and gene therapy research. North America leads the market, accounting for 45.3% of the total value in 2023.
The Global Metagenomic Sequencing Market is projected to grow from US$ 1.41 billion in 2023 to US$ 4.39 billion by 2030, with a CAGR of 17.6%. Key factors driving this growth include increased demand, technological advancements, and a broadening customer base, alongside insights into competitive dynamics and market segmentation. Major players include Illumina, QIAGEN, and Thermo Fisher Scientific, with applications spanning drug discovery, disease diagnosis, and environmental remediation.
SNIPR BIOME ApS has initiated the first human clinical trial for SNIPR001, targeting E. coli colonization in healthy volunteers, set to begin in the first half of 2022. The global CRISPR technology market is projected to grow significantly, with North America leading in market share, driven by advancements in biomedical applications and increasing research activities.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
